Adverse Events following 12 and 18 Month Vaccinations: a Population-Based, Self-Controlled Case Series Analysis

Article English OPEN
Kumanan Wilson; Steven Hawken; Jeffrey C Kwong; Shelley Deeks; Natasha S Crowcroft; Carl Van Walraven; Beth K Potter; Pranesh Chakraborty; Jennifer Keelan; Michael Pluscauskas; Doug Manuel;
(2011)
  • Publisher: Public Library of Science
  • Journal: PLoS ONE,volume 6,issue 12 (issn: 1932-6203, eissn: 1932-6203)
  • Publisher copyright policies & self-archiving
  • Related identifiers: pmc: PMC3236196, doi: 10.1371/journal.pone.0027897
  • Subject: Research Article | Mathematics | Vaccines | Infectious Disease Control | Infectious Diseases | Immunity | Epidemiology | Viral Vaccines | Immunizations | Rubella | Public Health | Biostatistics | Biology | Microbiology | Medicine | Viral Diseases | Pediatric Epidemiology | Q | R | Virology | Clinical Immunology | Science | Pediatrics | Measles | Statistics | Vaccination

BACKGROUND: Live vaccines have distinct safety profiles, potentially causing systemic reactions one to 2 weeks after administration. In the province of Ontario, Canada, live MMR vaccine is currently recommended at age 12 months and 18 months. METHODS: Using the self-con... View more
Share - Bookmark